Form 4: Colgate-Palmolive Director Brian Newman Reports Stock and Option Grants
SEC Form 4 Filing
Director Brian Newman reports acquisition of stock and stock options from Colgate-Palmolive's incentive compensation plan.
Summary
- Brian Newman, a director of Colgate-Palmolive, filed a Form 4 detailing changes in beneficial ownership.
- On May 12, 2025, Newman acquired 2,019 shares of common stock as an annual director stock grant under the issuer's incentive compensation plan.
- On the same date, Newman also acquired 2,272 stock options as an annual director stock option grant under the issuer's incentive compensation plan, exercisable in equal annual installments over three years beginning May 12, 2026.
- Newman disposed of 4,621 shares of common stock.
- Following the reported transactions, Newman directly owns 2,272 derivative securities and 4,621 shares of common stock, and indirectly owns 36 shares of common stock through a family trust.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices. The grants align director interests with shareholders.
Positives
- The grant of stock and options aligns the director's interests with those of the shareholders.
- The vesting schedule of the options encourages long-term commitment from the director.
Future Outlook
NA
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects standard practices for incentivizing directors and aligning their interests with shareholders.
Comparison to Industry Standards
- Stock option grants are a common component of executive compensation packages in publicly traded companies, including Colgate-Palmolive's peers such as Procter & Gamble (PG) and Unilever (UL).
- The vesting schedule of three years is also a standard practice to ensure long-term commitment.
- The size of the grant is likely determined by Colgate-Palmolive's compensation committee based on industry benchmarks and the director's contributions.
Stakeholder Impact
- The stock and option grants align the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
- The grants have no immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/12/2025 | Date of stock and option grant, and disposal of stock. |
| 05/12/2026 | First anniversary of the grant date; options become exercisable in installments. |
| 05/12/2033 | Expiration date of the stock options. |
| 05/14/2025 | Date of Form 4 filing. |
Keywords
Form 4, Director, Stock Options, Stock Grant, Beneficial Ownership, Colgate-Palmolive, Newman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.